Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 19:27 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Effects of DPP4 Inhibition on COVID-19
NCT04341935 · University of Miami · PHASE4 · withdrawn · last registry update 2021-06-10 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Logistical challenges amid COVID-19 pandemic and lack of financial support” | – | Registry record, University of Miami |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against DPP4 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-05-31Also stopped (terminated): AstraZeneca, Dapagliflozin 10 mg + Dapagliflozin 5 mg (NCT03608358)
- 2022-05-11Phase 3 first posted: Tanta University, Alpha lipoic acid + Roflumilast (NCT05369793)
- 2022-03-24Also stopped (withdrawn): University at Buffalo, sitagliptin + Placebo (NCT01741103)
- 2022-03-22Phase 3 first posted: National University of Malaysia, Dipeptidyl-Peptidase IV Inhibitors (NCT05290506)
- 2022-03-14Results posted on the registry: Population Health Research Institute, insulin glargine + sitagliptin/metformin (NCT02623998)
- 2022-02-09Results posted on the registry: University of Pennsylvania, Sitagliptin + Placebo (NCT01879228)
- 2022-02-02Phase 3 first posted: University of Milan, Sitagliptin (NCT05219409)
- 2022-01-28Results posted on the registry: Tanabe Pharma Corporation, Teneligliptin 20mg + Placebo (NCT02916706)
- 2022-01-28Results posted on the registry: Tanabe Pharma Corporation, Teneligliptin 20mg + Placebo (NCT02924064)
- 2021-12-08Phase 3 first posted: The First Affiliated Hospital of Soochow University, Sitagliptin + Standard Prophylaxis + Standard Prophylaxis (NCT05149365)
- 2021-12-03Phase 3 first posted: REDNVIA Co., Ltd., Evogliptin + Placebo (NCT05143177)
- 2021-11-01Phase 3 first posted: PegBio Co., Ltd., PB-201 + Vildagliptin (NCT05102149)
- 2021-10-11Also stopped (withdrawn): Rush University Medical Center, metformin and sitagliptin + insulin glargine and insulin lispro (NCT02250794)
- 2021-07-26Results posted on the registry: Vanderbilt University, Placebo + Sitagliptin (NCT02130687)
- 2021-07-22Results posted on the registry: Theracos, Bexagliflozin + Metformin (NCT02956044)
- 2021-06-29Results posted on the registry: Washington University School of Medicine, Sitagliptin + Placebo (NCT01928199)
- 2021-06-18Results posted on the registry: AstraZeneca, Saxagliptin + Sitagliptin (NCT02917031)
- 2021-06-04Results posted on the registry: Theracos, Bexagliflozin + Sitagliptin (NCT03115112)
- 2021-06-02Also stopped (terminated): Rabin Medical Center, Linagliptin 5 MG (NCT04371978)
- 2021-05-13Results posted on the registry: Nick Giannoukakis, PhD, Metformin + saxagliptin (NCT02597101)
- 2021-05-03Results posted on the registry: David D'Alessio, M.D., Active Comparator: Sitagliptin + Placebo Comparator - No Sitagliptin (NCT02683187)
- 2021-04-12Phase 3 first posted: Laboratorios Silanes S.A. de C.V., A1=Glimepiride / Vildagliptin / Metformin (1 mg/ 50 mg/ 500 mg) + B2=Glimepiride / Vildagliptin / Metformin (1 mg/ 50 mg/ 500 mg) (NCT04841096)
- 2021-04-05Results posted on the registry: University of Colorado, Denver, Sitagliptin Phosphate (NCT00795275)
- 2021-03-16Phase 3 first posted: Cadila Pharnmaceuticals, CPL-2009-0031 140 mg + Sitagliptin 100mg (NCT04801199)
- 2021-02-21Results posted on the registry: Profil Institut für Stoffwechselforschung GmbH, Sitagliptin 100 mg + Placebo (NCT03359590)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision